arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Lakefront Biotherapeutics

LKFT Health Care Biotechnology: Pharmaceutical Preparations
$31.40
▲ +2.1% Today
as of Oct 23, 09:20 ET
Last 30 days +17.56% Sep 14 → Oct 22
$26.33 $27.69 $29.05 $30.42 $31.78 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$30.62
High
$31.48
Low
$30.55
Volume
$307,945
Avg Vol
$180,709
Mkt Cap
$1.9B
P/E (TTM)
—
Beta
—
52w High
$36.24
52w Low
$25.68
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 12 items

Oct 21 · 15:00 Zacks
Lakefront Biotherapeutics - Sponsored ADR (LKFT) Upgraded to Buy: What Does It Mean for the Stock?
Oct 21 · 05:16 Simply Wall St.
Lakefront Biotherapeutics (ENXTAM:LKFT) Stock Looks Undervalued Despite A 40% Five Year Fall
Oct 14 · 20:23 MT Newswires
Lakefront Biotherapeutics Sells Preclinical CAR-T Programs to Armed Cell Therapeutics
▸ Show all 12 press releases & news Free account →

LKFT earnings at a glance

The options market is pricing a move of about ±17.4% after the report, a range of roughly $25.95 to $36.85 from today's $31.40. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±1.6% on average; after the most recent report on May 6, 2026 it moved +1.5%. That means options currently expect more movement than LKFT has typically delivered. LKFT beat the consensus EPS estimate in 1 of its last 2 reported quarters. Implied volatility is currently 111%. The share price of $31.40 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$26
$36
54% of range
Avg surprise (last 2)
-427.1%
Avg reaction (last 2)
+1.6%
100% positive
Latest IV / EM
111%
EM ±17.4% · $30 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.47$-1.79$-1.11$-0.43$0.25 Actual $-2.47Est $-0.23Actual $0.25Est $-1.27 Mar/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 6, 2026Mar/2026 $0.25 $-1.27 +119.7% +110.1% +1.5% earnings
Wed Apr 23, 2025Mar/2025 $-2.47 $-0.23 -973.9% — +1.7% earnings

Implied volatility — last 90 days

8%83%157%232%307% Jun 10 — IV 175% · EM ±20.6%Jul 27 — IV 85% · EM ±17.8%Jul 28 — IV 87% · EM ±17.8%Jul 30 — IV 107% · EM ±21.0%Jul 31 — IV 10% · EM ±1.8%Aug 03 — IV 8% · EM ±1.5%Aug 04 — IV 21% · EM ±3.6%Aug 07 — IV 9% · EM ±1.5%Aug 14 — IV 164% · EM ±18.2%Aug 18 — IV 257% · EM ±18.6%Aug 24 — IV 82% · EM ±17.2%Aug 25 — IV 62% · EM ±12.6%Aug 26 — IV 89% · EM ±17.8%Aug 27 — IV 53% · EM ±10.4%Sep 08 — IV 137% · EM ±18.1%Sep 09 — IV 148% · EM ±18.6%Sep 10 — IV 157% · EM ±18.6%Sep 15 — IV 280% · EM ±20.2%Sep 16 — IV 308% · EM ±18.2%Sep 21 — IV 81% · EM ±16.9%Sep 25 — IV 84% · EM ±16.2%Sep 28 — IV 96% · EM ±16.9%Oct 02 — IV 111% · EM ±17.4%

Sector peers

AGIO
Agios Pharmaceuticals, Inc.
$1.9B $37.19+1.5%
GPCR
Structure Therapeutics Inc.
$1.9B $21.93-4.2%
XNCR
Xencor, Inc.
$1.8B $25.84+3.6%
MRVI
Maravai LifeSciences Holdings, Inc.
$1.9B $7.07-1.8%
HCM
HUTCHMED (China) Limited
$2.0B $14.28-3.1%
TRVI
Trevi Therapeutics, Inc.
$2.0B $12.94+0.9%

LKFT earnings FAQ

What is LKFT's expected move for earnings?

Options currently price a move of about ±17.4%, or $5.45 per share either way from $31.40.

How does LKFT stock usually react to earnings?

Across the last 2 reports the average next-day move was ±1.6%, up 2 times and down 0 times.

What is LKFT's implied volatility?

LKFT's at-the-money implied volatility is about 111% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in